What You Should Know:
- TetraScience, a provider of scientific data cloud solutions announced a strategic collaboration with Microsoft to accelerate the adoption of artificial intelligence (AI) in the biopharmaceutical industry.
- The strategic partnership combines TetraScience's Scientific Data and AI Cloud with the power and security of Microsoft Azure, creating a robust platform for scientific organizations to extract valuable insights from their complex experimental
Read More
Biopharma | News, Analysis, Insights - HIT Consultant
Pangea Biomed’s ENLIGHT-DP Predicts Cancer Treatment Response from Simple Scans
What You Should Know:
- Pangea Biomed, a leader in precision oncology, announced a significant breakthrough in its ENLIGHT cancer response predictor. A new study published in Nature Cancer demonstrates the effectiveness of their ENLIGHT-DP platform, revealing its ability to predict cancer treatment response across various types and drugs using only routine pathology slides.
- While these findings are promising, further validation and testing are planned for regulatory
Read More
Biopharma at a Crossroads: AI Offers Key to R&D Reinvention
What You Should Know:
- A new report by Accenture, "Reinventing R&D in the Age of AI," paints a clear picture: the biopharmaceutical industry stands at a critical juncture. Companies that embrace intelligent technologies like AI and machine learning are poised to become the future's leaders, while those clinging to outdated methods risk falling behind.
- Accenture's report serves as a roadmap, offering valuable insights and practical steps for companies ready to embrace the
Read More
JAPAC Drug Development: Navigating Safety & Regulatory Requirements
The biopharmaceutical market within the Japan and Asia-Pacific (JAPAC) region has grown consistently since 2010, specifically for emerging biopharmas (EBPs). In fact, in 2018, 80% of all biopharma pipeline projects in JAPAC were EBPs, accounting for 75% of the total clinical trial volume in the region. This growth benefits contract research organizations, pharma organizations and patients alike, but several factors must be considered for drug development safety and regulatory operations in JAPAC
Read More
Israel Innovation Authority to Invest $31M to Establish R&D Infrastructure Center for Bio-Chips-Based Bio-Devices
What You Should Know:
The Israel Innovation Authority announced today a NIS 113M ($31M USD) investment for the establishment of a center that will provide research and development (R&D) infrastructure for bio-devices based on bio-chips. The investment is part of the National Bio-Convergence Program.Bio-convergence represents the integration of biology and life sciences with engineering and software technologies. The investment is directed at companies dedicated to developing key
Read More
Walgreens and Freenome Partner to Increase Diversity in Research
What You Should Know:
Walgreens and Freenome form a multi-year relationship to advance clinical studies of Freenome’s blood-based tests for the early detection of cancer. Walgreens will combine its national footprint, patient insights, compliant recruitment technology and local infrastructure to engage diverse patient populations in Freenome’s multi-cancer research program. Walgreens will initially recruit patients across diverse populations for Freenome’s Sanderson Study, which aims to
Read More
Navigating the Challenges of Biosample Consent in Clinical Trials
In the age of biotechnology, biosample collection has become an essential part of medical research. Through this process, samples are taken from patients through a variety of sources, including blood, tissue, saliva, hair, and other bodily fluids. The samples are then analyzed for their genetic, biochemical, or physiological properties, and the findings are used to further the understanding of human health, disease and the environment.
Many times, during clinical trials, sponsors will want to
Read More
3 Ways Government Can Catalyze Biomedical Innovation
What You Should Know:
Deloitte has published some new research about how government can advance biomedical innovation and improve public health.The report shares insights from various government leaders and biomedical industry experts on lessons learned from the COVID-19 pandemic, what’s driving innovation, the challenges and opportunities in partnerships, and the government’s role in sustaining the biomedical industry.
Understanding How the Government Can Catalyze Biomedical
Read More
Genemod Raises $4.5M to Expand Central Research Platform for Biopharma Companies
What You Should Know:
Genemod, a cloud-based workspace collaboration software for biopharma R&D teams, today announced it raised $4.5 million in seed funding, co-led by defy.vc and LDV Partners, with participation from Dolby Family Ventures and Vulcan/Cercano Ventures.Genemod digitizes data capture and workflows, so scientists can collaborate easily across an organization to accelerate life sciences R&D.
Digitize Research Workflows in Minutes
Legacy R&D software
Read More
What to Know About Gene Therapy
Gene therapy is making a world where cancer and AIDS can be cured, and a person can alter their genetic makeup, changing the direction of their own and their offspring's evolution in the process. However, the effects of gene therapy are long-lasting, and may impact both your and the health of your future children.
What Is Gene Therapy?
Utilizing a gene or genes to treat or cure a disease or medical condition is known as gene therapy. Gene therapy frequently involves replacing a
Read More
